Intercept Pharmaceuticals, Inc. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8d8ae36c-c5c4-4126-b65f-4764e49e41c5/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $221.8M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-002693 |
| FY 2021 | $-91.4M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002666 |
| FY 2020 | $-274.9M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-001804 |
| FY 2019 | $-344.7M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-001314 |
| FY 2018 | $-309.2M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-011650 |
| FY 2017 | $-360.4M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-011793 |
| FY 2016 | $-412.8M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-012180 |
| FY 2015 | $-226.4M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-085037 |
| FY 2014 | $-283.2M | 2014-01-01 – 2014-12-31 | evidence 0001144204-16-085037 |
| FY 2013 | $-443.6M | 2002-09-04 – 2014-03-31 | evidence 0001144204-14-029145 |
| FY 2012 | $-128.4M | 2002-09-04 – 2013-03-31 | evidence 0001144204-13-028848 |
| FY 2011 | $-12.7M | 2011-01-01 – 2011-12-31 | evidence 0001144204-13-019166 |
| FY 2010 | $-15.1M | 2010-01-01 – 2010-12-31 | evidence 0001144204-13-019166 |
| FY 2009 | $-14.4M | 2009-01-01 – 2009-12-31 | evidence 0001144204-13-019166 |
| FY 2008 | $-13.7M | 2008-01-01 – 2008-12-31 | evidence 0001144204-13-019166 |
| FY 2007 | $-18.7M | 2002-09-04 – 2007-12-31 | evidence 0001144204-13-019166 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Intercept Pharmaceuticals, Inc. — all facts · Revenue · Operating Income